Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors Cancer

Explore clinical trials studying Advanced Solid Tumors Cancer. Study availability and eligibility vary by location and protocol.

20 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumors Cancer trial results

Completed

A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

NCT04196283

Conditions
Advanced Solid Tumors Cancer, Carcinoma, Carcinoma, Squamous Cell, +7 more
Locations
  • The University of Chicago Medical Center /ID# 217196 Chicago, Illinois, United States
  • Norton Cancer Institute /ID# 216179 Louisville, Kentucky, United States
  • Barbara Ann Karmanos Cancer In /ID# 214050 Detroit, Michigan, United States
  • Nebraska Methodist Hospital /ID# 215786 Omaha, Nebraska, United States
View all 26 locations
View Trial Details
Completed

A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT03071757

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +58 more
Locations
  • Moores Cancer Center at UC San Diego /ID# 201334 La Jolla, California, United States
  • University of California, Davis Comprehensive Cancer Center /ID# 201342 Sacramento, California, United States
  • Stanford University /ID# 206949 Stanford, California, United States
  • Yale University /ID# 207895 New Haven, Connecticut, United States
View all 27 locations
View Trial Details
Completed

A Study Evaluating the Safety, Pharmacokinetics, and Anti-tumor Activity of ABBV-321 in Subjects With Advanced Solid Tumors Associated With Overexpression of the Epidermal Growth Factor Receptor (EGFR)

NCT03234712

Conditions
Advanced Solid Tumors Cancer, Astrocytoma, Bronchial Neoplasms, +21 more
Locations
  • Highlands Oncology Group /ID# 166132 Springdale, Arkansas, United States
  • The Angeles Clinic and Researc /ID# 166133 Los Angeles, California, United States
  • University of California, Davis Comprehensive Cancer Center /ID# 215012 Sacramento, California, United States
  • Northwestern University Feinberg School of Medicine /ID# 165191 Chicago, Illinois, United States
View all 18 locations
View Trial Details
Completed

A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid Tumors

NCT02955251

Conditions
Adnexal Diseases, Advanced Solid Tumors Cancer, Bronchial Neoplasms, +21 more
Locations
  • HonorHealth Research Institute - Pima /ID# 155461 Scottsdale, Arizona, United States
  • UC Davis Comprehensive Cancer Center - Main /ID# 154439 Sacramento, California, United States
  • University of Chicago /ID# 154440 Chicago, Illinois, United States
  • Fox Chase Cancer Center /ID# 170665 Philadelphia, Pennsylvania, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors

NCT02988960

Conditions
Advanced Solid Tumors Cancer, Bronchial Neoplasms, Carcinoma, +23 more
Locations
  • The Angeles Clinic and Researc /ID# 156324 Los Angeles, California, United States
  • The University of Chicago Medical Center /ID# 155264 Chicago, Illinois, United States
  • Massachusetts General Hospital /ID# 155267 Boston, Massachusetts, United States
  • Carolina BioOncology Institute /ID# 155265 Huntersville, North Carolina, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid Tumors

NCT02099058

Conditions
Advanced Solid Tumors Cancer, Neoplasms
Locations
  • Scottsdale Healthcare /ID# 123761 Scottsdale, Arizona, United States
  • City of Hope /ID# 153759 Duarte, California, United States
  • University of California, Los Angeles /ID# 148295 Los Angeles, California, United States
  • UC Irvine /ID# 165107 Orange, California, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors

NCT04721015

Conditions
Advanced Solid Tumors Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Dana-Farber Cancer Institute /ID# 231209 Boston, Massachusetts, United States
  • Washington University-School of Medicine /ID# 225698 St Louis, Missouri, United States
  • Carolina BioOncology Institute /ID# 225358 Huntersville, North Carolina, United States
  • Lifespan Cancer Institute at Rhode Island Hospital /ID# 226145 Providence, Rhode Island, United States
View all 33 locations
View Trial Details
Active, Not Recruiting

Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors

NCT03821935

Conditions
Adenocarcinoma, Advanced Solid Tumors Cancer, Breast Diseases, +28 more
Locations
  • Highlands Oncology Group, PA /ID# 218942 Springdale, Arkansas, United States
  • City of Hope National Medical Center /ID# 265620 Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center /ID# 270785 Irvine, California, United States
  • Yale University School of Medicine /ID# 208356 New Haven, Connecticut, United States
View all 64 locations
View Trial Details

Related conditions